ABBOTT LABORATORIES Total Liabilities & Equity 2007-2026 | ABT
Beta
What is total liabilities & equity?
Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.
What is ABBOTT LABORATORIES's current total liabilities & equity?
ABBOTT LABORATORIES (ABT) annual total liabilities & equity for 2025 was $86.71B, a 6.51% increase from 2024. ABBOTT LABORATORIES total liabilities & equity for the quarter ending March 31, 2026 was $110.43B.
What was ABBOTT LABORATORIES's total liabilities & equity in 2024?
ABBOTT LABORATORIES annual total liabilities & equity for 2024 was $81.41B, a 11.20% increase from 2023.
What was ABBOTT LABORATORIES's total liabilities & equity in 2023?
ABBOTT LABORATORIES annual total liabilities & equity for 2023 was $73.21B, a 1.64% decline from 2022.
What is ABBOTT LABORATORIES's 5-year total liabilities & equity CAGR?
ABBOTT LABORATORIES total liabilities & equity grew at a compound annual growth rate (CAGR) of 3.63% from FY2020 to FY2025, going from $72.55B to $86.71B over 5 years.
Total Liabilities & Equity History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+3.6%
FY2020
$72.55B
→
FY2025
$86.71B
07080910111213141516171819202122232425
5 years selected
Total Liabilities & Equity History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $86.71B | +6.5% | 10-K |
| FY2024 | $81.41B | +11.2% | 10-K |
| FY2023 | $73.21B | -1.6% | 10-K |
| FY2022 | $74.44B | -1.0% | 10-K |
| FY2021 | $75.20B | +3.6% | 10-K |
| FY2020 | $72.55B | +6.9% | 10-K |
| FY2019 | $67.89B | +1.1% | 10-K |
| FY2018 | $67.17B | -11.9% | 10-K |
| FY2017 | $76.25B | +44.8% | 10-K |
| FY2016 | $52.67B | +27.7% | 10-K |
| FY2015 | $41.25B | +0.1% | 10-K |
| FY2014 | $41.21B | -4.1% | 10-K |
| FY2013 | $42.95B | -36.1% | 10-K |
| FY2012 | $67.23B | +11.5% | 10-K |
| FY2011 | $60.28B | -0.5% | 10-K |
| FY2010 | $60.57B | +15.2% | 10-K |
| FY2009 | $52.58B | +24.0% | 10-K |
| FY2008 | $42.42B | +6.8% | 10-K |
| FY2007 | $39.71B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →